+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Anti-Infective Drugs Global Market Report 2020-30: COVID-19 Implications and Growth

  • ID: 5028638
  • Report
  • May 2020
  • Region: Global
  • 300 pages
  • The Business Research Company
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Gilead
  • GlaxosmithKline
  • Johnson & Johnson
  • Merck & Co
  • MORE
Anti-Infective Drugs Global Market Report 2020-30: COVID-19 Implications and Growth from the publisher covers this critical market and the impact on it from the COVID-19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for anti-infective drugs which play a critical role in the treatment of patients with COVID-19.

Anti-Infective drugs help cure patients suffering from viral diseases including Covid-19.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3 working days of order.
Description:
Where is the largest and fastest growing market for the anti-infective drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Anti-Infective Drugs Market global report from the publisher answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider anti-infective drugs market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The anti-infective drugs market section of the report gives context. It compares the anti-infective drugs market with other segments of the anti-infective drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, anti-infective drugs indicators comparison.
Scope

Markets Covered:
1) By Type: Antibiotics; Antivirals; Antifungals; Others (Anthelminthic, Antiprotozoal)
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Gilead; Merck & Co; GlaxosmithKline; Bristol-Myers Squibb Company; Johnson & Johnson

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, anti-infective drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Gilead
  • GlaxosmithKline
  • Johnson & Johnson
  • Merck & Co
  • MORE
1. Executive Summary

2. Report Structure

3. Anti-Infective Drugs Market Characteristics
3.1. Market Definition
3.2. Key Segmentations

4. Anti-Infective Drugs Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products

5. Anti-Infective Drugs Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers

6. Anti-Infective Drugs Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth

7. Anti-Infective Drugs Market Trends And Strategies

8. Anti-Infective Drugs Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, Value ($ Billion)
8.2.1. Drivers Of The Market
8.2.2. Restraints On The Market
8.3. Forecast Market Growth, Value ($ Billion)
8.3.1. Drivers Of The Market
8.3.2. Restraints On The Market

9. Anti-Infective Drugs Market Regional Analysis
9.1. Global Anti-Infective Drugs Market, 2019, By Region, Value ($ Billion)
9.2. Global Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
9.3. Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region

10. Anti-Infective Drugs Market Segmentation
10.1. Global Anti-Infective Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Antibiotics
  • Antivirals
  • Antifungals
  • Others (Anthelminthic, Antiprotozoal)
10.2. Global Anti-Infective Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
10.3. Global Anti-Infective Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Oral
  • Parenteral
  • Others
10.4. Global Anti-Infective Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Branded Drugs
  • Generic Drugs
10.5. Global Anti-Infective Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs
11. Anti-Infective Drugs Market Metrics
11.1. Anti-Infective Drugs Market Size, Percentage Of GDP, 2015-2023, Global
11.2. Per Capita Average Anti-Infective Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Anti-Infective Drugs Market
12.1. Asia-Pacific Anti-Infective Drugs Market Overview
12.2. Asia-Pacific, Anti-Infective Drugs Market, 2019, By Country, Value ($ Billion)
12.3. Asia-Pacific, Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
12.4. Asia-Pacific, Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
12.5. Asia-Pacific, Anti-Infective Drugs Market Metrics
12.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2015-2023, Asia-Pacific Countries
12.6. Asia-Pacific Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7. Asia-Pacific Anti-Infective Drugs Market: Country Analysis
12.7.1. China Anti-Infective Drugs Market
12.7.1.1. China Anti-Infective Drugs Market Overview
12.7.1.2. China Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.1.3. China Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.2. Australia Anti-Infective Drugs Market
12.7.2.1. Australia Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.2.2. Australia Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.3. Hong Kong Anti-Infective Drugs Market
12.7.3.1. Hong Kong Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.4. India Anti-Infective Drugs Market
12.7.4.1. India Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.4.2. India Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.5. Indonesia Anti-Infective Drugs Market
12.7.5.1. Indonesia Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.5.2. Indonesia Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.6. Japan Anti-Infective Drugs Market
12.7.6.1. Japan Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.6.2. Japan Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.7. Malaysia Anti-Infective Drugs Market
12.7.7.1. Malaysia Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.8. New Zealand Anti-Infective Drugs Market
12.7.8.1. New Zealand Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.9. Philippines Anti-Infective Drugs Market
12.7.9.1. Philippines Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.10. Singapore Anti-Infective Drugs Market
12.7.10.1. Singapore Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.11. South Korea Anti-Infective Drugs Market
12.7.11.1. South Korea Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.11.2. South Korea Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.12. Thailand Anti-Infective Drugs Market
12.7.12.1. Thailand Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.13. Vietnam Anti-Infective Drugs Market
12.7.13.1. Vietnam Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Anti-Infective Drugs Market
13.1. Western Europe Anti-Infective Drugs Market Overview
13.2. Western Europe, Anti-Infective Drugs Market, 2019, By Country, Value ($ Billion)
13.3. Western Europe, Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
13.4. Western Europe, Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
13.5. Western Europe, Anti-Infective Drugs Market Metrics
13.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2015-2023, Western Europe Countries
13.6. Western Europe Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7. Western Europe Anti-Infective Drugs Market: Country Analysis
13.7.1. Austria Anti-Infective Drugs Market
13.7.1.1. Austria Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.2. Belgium Anti-Infective Drugs Market
13.7.2.1. Belgium Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.3. Denmark Anti-Infective Drugs Market
13.7.3.1. Denmark Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.4. Finland Anti-Infective Drugs Market
13.7.4.1. Finland Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.5. France Anti-Infective Drugs Market
13.7.5.1. France Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.5.2. France Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.6. Germany Anti-Infective Drugs Market
13.7.6.1. Germany Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.6.2. Germany Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.7. Ireland Anti-Infective Drugs Market
13.7.7.1. Ireland Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.8. Italy Anti-Infective Drugs Market
13.7.8.1. Italy Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.9. Netherlands Anti-Infective Drugs Market
13.7.9.1. Netherlands Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.10. Norway Anti-Infective Drugs Market
13.7.10.1. Norway Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.11. Portugal Anti-Infective Drugs Market
13.7.11.1. Portugal Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.12. Spain Anti-Infective Drugs Market
13.7.12.1. Spain Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.13. Sweden Anti-Infective Drugs Market
13.7.13.1. Sweden Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.14. Switzerland Anti-Infective Drugs Market
13.7.14.1. Switzerland Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.15. UK Anti-Infective Drugs Market
13.7.15.1. UK Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.15.2. UK Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Anti-Infective Drugs Market
14.1. Eastern Europe Anti-Infective Drugs Market Overview
14.2. Eastern Europe, Anti-Infective Drugs Market, 2019, By Country, Value ($ Billion)
14.3. Eastern Europe, Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
14.4. Eastern Europe, Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
14.5. Eastern Europe, Anti-Infective Drugs Market Metrics
14.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2015-2023, Eastern Europe Countries
14.6. Eastern Europe Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7. Eastern Europe Anti-Infective Drugs Market: Country Analysis
14.7.1. Czech Republic Anti-Infective Drugs Market,
14.7.1.1. Czech Republic Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.2. Poland Anti-Infective Drugs Market
14.7.2.1. Poland Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.3. Romania Anti-Infective Drugs Market
14.7.3.1. Romania Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.4. Russia Anti-Infective Drugs Market
14.7.4.1. Russia Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.4.2. Russia Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Anti-Infective Drugs Market
15.1. North America Anti-Infective Drugs Market Overview
15.2. North America, Anti-Infective Drugs Market, 2019, By Country, Value ($ Billion)
15.3. North America, Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
15.4. North America, Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
15.5. North America, Anti-Infective Drugs Market Metrics
15.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2015-2023, North America Countries
15.6. North America Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7. North America Anti-Infective Drugs Market: Country Analysis
15.7.1. Canada Anti-Infective Drugs Market
15.7.1.1. Canada Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.2. Mexico Anti-Infective Drugs Market
15.7.2.1. Mexico Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.3. USA Anti-Infective Drugs Market
15.7.3.1. USA Anti-Infective Drugs Market Overview
15.7.3.2. USA Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.3.3. USA Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Anti-Infective Drugs Market
16.1. South America Anti-Infective Drugs Market Overview
16.2. South America, Anti-Infective Drugs Market, 2019, By Country, Value ($ Billion)
16.3. South America, Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
16.4. South America, Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
16.5. South America, Anti-Infective Drugs Market Metrics
16.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2015-2023, South America Countries
16.6. South America Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7. South America Anti-Infective Drugs Market: Country Analysis
16.7.1. Argentina Anti-Infective Drugs Market
16.7.1.1. Argentina Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.2. Brazil Anti-Infective Drugs Market
16.7.1.1. Brazil Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.2.2. Brazil Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.3. Chile Anti-Infective Drugs Market
16.7.3.1. Chile Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.4. Colombia Anti-Infective Drugs Market
16.7.4.1. Colombia Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.5. Peru Anti-Infective Drugs Market
16.7.5.1. Peru Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.6. Venezuela Anti-Infective Drugs Market
16.7.6.1. Venezuela Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. Middle East Anti-Infective Drugs Market
17.1. Middle East Anti-Infective Drugs Market Overview
17.2. Middle East, Anti-Infective Drugs Market, 2019, By Country, Value ($ Billion)
17.3. Middle East, Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
17.4. Middle East, Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
17.5. Middle East, Anti-Infective Drugs Market Metrics
17.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2015-2023, Middle East Countries
17.6. Middle East Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7. Middle East Anti-Infective Drugs Market: Country Analysis
17.7.1. Saudi Arabia Anti-Infective Drugs Market
17.7.1.1. Saudi Arabia Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.2. Israel Anti-Infective Drugs Market
17.7.2.1. Israel Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.3. Turkey Anti-Infective Drugs Market
17.7.3.1. Turkey Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.4. UAE Anti-Infective Drugs Market
17.7.4.1. UAE Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Anti-Infective Drugs Market
18.1. Africa Anti-Infective Drugs Market Overview
18.2. Africa, Anti-Infective Drugs Market, 2019, By Country, Value ($ Billion)
18.3. Africa, Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
18.4. Africa, Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
18.5. Africa, Anti-Infective Drugs Market Metrics
18.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2015-2023, Africa Countries
18.6. Africa Anti-Infective Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7. Africa Anti-Infective Drugs Market: Country Analysis
18.7.1. Egypt Anti-Infective Drugs Market
18.7.1.1. Egypt Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.2. Nigeria Anti-Infective Drugs Market
18.7.2.1. Nigeria Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.3. South Africa Anti-Infective Drugs Market
18.7.3.1. South Africa Anti-Infective Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Anti-Infective Drugs Market Competitive Landscape
19.1. Competitive Market Overview
19.2. Market Shares
19.3. Company Profiles
19.3.1. Gilead
19.3.1.1. Company Overview
19.3.1.2. Products And Services
19.3.1.3. Strategy
19.3.1.4. Financial Performance
19.3.2. Merck & Co
19.3.2.1. Company Overview
19.3.2.2. Products And Services
19.3.2.3. Strategy
19.3.2.4. Financial Performance
19.3.3. GlaxosmithKline
19.3.3.1. Company Overview
19.3.3.2. Products And Services
19.3.3.3. Strategy
19.3.3.4. Financial Performance
19.3.4. Bristol-Myers Squibb Company
19.3.4.1. Company Overview
19.3.4.2. Products And Services
19.3.4.3. Strategy
19.3.4.4. Financial Performance
19.3.5. Johnson & Johnson
19.3.5.1. Company Overview
19.3.5.2. Products And Services
19.3.5.3. Strategy
19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Anti-Infective Drugs Market

21. Market Background: Pharmaceutical Drugs Market
21.1. Pharmaceutical Drugs Market Characteristics
21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

22. Recommendations
22.1. Global Anti-Infective Drugs Market In 2023- Growth Countries
22.2. Global Anti-Infective Drugs Market In 2023- Growth Segments
22.3. Global Anti-Infective Drugs Market In 2023- Growth Strategies

23. Appendix
23.1. NAICS Definitions Of Industry Covered In This Report
23.2. Abbreviations
23.3. Currencies
23.4. Research Inquiries
23.5. About the Publisher

24. Copyright And Disclaimer
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Gilead
  • GlaxosmithKline
  • Johnson & Johnson
  • Merck & Co
  • MORE
North America was the largest region in the global anti-infective drugs market, accounting for 50% of the market in 2019. Asia Pacific was the second largest region accounting for 20% of the global anti-infective drugs market. Africa was the smallest region in the global anti-infective drugs market.

Companies in this market are active with multiple strategic collaborations and agreements. Top companies in the anti-infective drug market are strategically partnering and collaborating with other companies to broaden their products and services. For instance, in May 2015, Janssen Pharmaceuticals Inc., subsidiary of Johnson & Johnson has entered into an exclusive worldwide license and collaboration arrangement with Achillion Pharmaceuticals Inc. to develop and commercialize one or more of Achillion's lead hepatitis C virus (HCV) assets which include ACH-3102, ACH-3422 and sovaprevir . Also in December 2017, Evotec AG was in a strategic alliance with Forge Therapeutics Inc. to advance its novel Gram-negative antibiotic programme targeting 'LpxC' for the treatment of bacterial infections. Chimerix and ContraVir Pharmaceuticals also entered into a strategic collaboration for antiviral drug candidate CMX157.

The anti-infective drugs market consists of sales of anti-infective drugs and related services by entities (organizations, sole traders and partnerships) that produce anti-infective drugs to treat microbial infections. This industry includes establishments that produce antibiotics to treat bacterial infections, anti-viral drugs to treat viral infections, anti-fungal drugs to treat fungal infections, anti- helminthic drugs to kill internal parasites and antiprotozoal agents.

The global anti-infective drugs market is expected to grow from $106.5 billion in 2019 to $139.3 billion in 2020 at a compound annual growth rate (CAGR) of 30.8%. The significant growth is mainly due to the COVID-19 outbreak and the huge demand for anti-viral and antibiotic drugs. Although other anti-infective drugs like antifungals have seen a dip in sales, the enormous demand for antiviral drugs and antibiotic drugs such as Azithromycin, Chloroquine, Acyclovir, and Ribavirin among others have contributed to the overall market growth of anti-infective drugs. The market is then expected to recover and grow at a CAGR of 6% from 2021 and reach $159.6 billion in 2023.
Note: Product cover images may vary from those shown
5 of 5
  • Gilead
  • Merck & Co
  • GlaxosmithKline
  • Bristol-Myers Squibb Company
  • Johnson & Johnson
Note: Product cover images may vary from those shown
6 of 5

Loading
LOADING...

Adroll
adroll